Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders

Author： Roth Bryan Hanizavareh S. Blum Andrew

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.174, Iss.1, 2004-06, pp. : 17-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Serotonin Receptors as Targets for Drugs Useful to Treat Psychosis and Cognitive Impairment in Schizophrenia

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1572-1586

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors as Therapeutic Targets for Cognitive Disorders

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 187-206

Bentham Science Publishers

Access to resources Recommend Favorite

Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists

By Friedman Joseph

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 45-53

Springer Publishing Company

Access to resources Recommend Favorite

Potassium channel subtypes as molecular targets for overactive bladder and other urological disorders

By Gopalakrishnan Murali Shieh Char-Chang

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 5, 2004-10 ,pp. : 437-458

Informa Healthcare

Access to resources Recommend Favorite

Neuronal Nicotinic Acetylcholine Receptors - Targets for the Development of Drugs to Treat Cognitive Impairment Associated with Schizophrenia and Alzheimer's Disease

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 144-152

Bentham Science Publishers

Access to resources Recommend Favorite